Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Parathyroid Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hyperparathyroidism, Primary 1

Interventions

Cisplatin 45pembrolizumab 35Magnetic Resonance Spectroscopy 32Specimen Handling 26Radiotherapy, Intensity-Modulated 21Cetuximab 18Nivolumab 17Carboplatin 16Platinum 151,2-diaminocyclohexaneplatinum II citrate 15Radiotherapy 13Biopsy 12Paclitaxel 10Gemcitabine 10Surveys and Questionnaires 9Radiation 9Docetaxel 9Immunoglobulin G 7Disulfides 7cemiplimab 6Ipilimumab 6Fluorouracil 6Bevacizumab 6toripalimab 5atezolizumab 5Watchful Waiting 5Taxes 5Immune Checkpoint Inhibitors 5Drug Therapy 5fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
fluorocholine × Head & Neck × 30 days × Clear all
NCT07444723 2026-05-12

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡